“The major modulators of aging remain to be discovered”
@BuckInstitute start-up Gerostate Alpha reveals work to develop small molecule drugs that simultaneously target multiple pathways of aging.
What do you do if you think targeting the #hallmarksofaging is a biased approach? Start a company, of course! Get the inside scoop on Buck-born startup Gerostate Alpha, which is using an unbiased drug screening approach to tackle key aging phenotypes. https://www.longevity.technology/the-major-modulators-of-aging-remain-to-be-discovered/
The first-ever issue of @NatureAging (insert birthday/longevity pun here), @EricVerdin and Herb Kasler provide commentary on new work from @Emma_S_Chambers and @Akbarlab describing the effects of #inflammaging on #adapativeimmunity
https://www.nature.com/articles/s43587-020-00021-3
The Buck seeks a new faculty member at the rank of Assistant Professor. We are looking for an individual who works in the field of Aging Research and/or Age-related diseases with a specific interest and expertise in Mass Spectrometry and Proteomics: https://app.jobvite.com/j?cj=oagrefwP&s=Social
